Home LiteratureArticle Details
PMID: 8612196 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis.

Molecular medicine (Cambridge, Mass.) ·Vol. 1 ·No. 7 ·1995-11-00 ·Pages 732-43

Vartanian T, Li Y, Zhao M, Stefansson K

Abstract

The histopathology of multiple sclerosis (MS) is characterized by a loss of myelin and oligodendrocytes, relative preservation of axons, and a modest inflammatory response. The reasons for this selective oligodendrocyte death and demyelination are unknown. In light of the T lymphocyte and macrophage infiltrates in MS lesions and the numerous cytokines these cells secrete, the direct influence of cytokines on survival of cultured oligodendrocytes and sensory neurons was investigated. Expression of cytokines in vivo was determined by immunolabeling cryostat sections of snap-frozen tissue containing chronic active lesions from four different patients. The samples were also analyzed for the presence of apoptotic nuclei by in situ labeling of 3'-OH ends of degraded nuclear DNA. The results showed: (i) interferon-gamma (IFN gamma) to be a potent inducer of apoptosis among oligodendrocytes in vitro and that this effect can be reversed by leukemia inhibitory factor (LIF); (ii) IFN gamma has a minimal effect on the survival of cultured neurons; (iii) IFN gamma at the margins of active MS plaques but not in unaffected white matter; (iv) evidence for apoptosis of oligodendrocytes at the advancing margins of chronic active MS plaques. Injury to a substantial number of oligodendrocytes in MS is the results of programmed cell death rather than necrotic cell death mechanisms. We postulate that IFN gamma plays a role in the pathogenesis of MS by activating apoptosis in oligodendrocytes.

MeSH Terms
Animals Antibodies/pharmacology Apoptosis Cells, Cultured DNA Damage Growth Inhibitors/pharmacology Humans Interferon-gamma/immunology,pharmacology Interleukin-6 Leukemia Inhibitory Factor Lymphokines/pharmacology Microglia/physiology Multiple Sclerosis/etiology Neurons, Afferent/drug effects Nitric Oxide/metabolism Oligodendroglia/cytology,drug effects,pathology Rats Stem Cells/cytology,drug effects,pathology Tetrazolium Salts/metabolism
Chemicals
Antibodies Growth Inhibitors Interleukin-6 LIF protein, human Leukemia Inhibitory Factor Lymphokines Tetrazolium Salts Nitric Oxide Interferon-gamma
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Vartanian T
Department of Neurology, Beth Israel Hospital, Boston, Massachusetts, USA.
Li Y
Zhao M
Stefansson K
References (51)
51 references, click to expand
  1. Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients.
    Acta Neurol Scand. 1993 Apr;87(4):281-5 PMID: 8503256
  2. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide.
    J Immunol. 1993 Aug 15;151(4):2132-41 PMID: 8102159
  3. Molecular regulation of apoptosis: genetic controls on cell death.
    Cell. 1993 Sep 10;74(5):777-9 PMID: 8104100
  4. Multiple extracellular signals are required for long-term oligodendrocyte survival.
    Development. 1993 May;118(1):283-95 PMID: 8375338
  5. Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor.
    Neuron. 1994 Feb;12(2):357-71 PMID: 7509160
  6. Glutamate regulates intracellular calcium and gene expression in oligodendrocyte progenitors through the activation of DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
    Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3215-9 PMID: 8159727
  7. Evidence for hypoxia-induced, programmed cell death of cultured neurons.
    Ann Neurol. 1994 Dec;36(6):864-70 PMID: 7998772
  8. Fine structural alterations of the blood-brain barrier in experimental allergic encephalomyelitis.
    J Neuropathol Exp Neurol. 1970 Jul;29(3):432-40 PMID: 5433206
  9. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.
    Br J Cancer. 1972 Aug;26(4):239-57 PMID: 4561027
  10. Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture.
    Nature. 1978 Aug 24;274(5673):813-6 PMID: 355894
  11. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.
    J Cell Biol. 1980 Jun;85(3):890-902 PMID: 6248568
  12. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.
    Lab Invest. 1981 Dec;45(6):534-46 PMID: 7321526
  13. Multiple sclerosis: distribution of T cell subsets within active chronic lesions.
    Science. 1983 Jan 21;219(4582):308-10 PMID: 6217550
  14. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium.
    Nature. 1983 Jun 2-8;303(5916):390-6 PMID: 6304520
  15. Interferons as macrophage-activating factors. II. Enhanced secretion of interleukin 1 by lipopolysaccharide-stimulated human monocytes.
    Eur J Immunol. 1983 Jun;13(6):437-40 PMID: 6345180
  16. CSF and serum interferon in multiple sclerosis: longitudinal study.
    Neurology. 1983 Dec;33(12):1604-6 PMID: 6196687
  17. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody.
    J Neuroimmunol. 1984 Sep-Oct;6(6):387-96 PMID: 6207204
  18. Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophy.
    Ann Neurol. 1985 Dec;18(6):660-4 PMID: 3909937
  19. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions.
    Ann Neurol. 1986 Jun;19(6):578-87 PMID: 3524414
  20. Characterization of ameboid microglia isolated from developing mammalian brain.
    J Neurosci. 1986 Aug;6(8):2163-78 PMID: 3018187
  21. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.
    Cancer Res. 1987 Feb 15;47(4):936-42 PMID: 3802100
  22. Exacerbations of multiple sclerosis in patients treated with gamma interferon.
    Lancet. 1987 Apr 18;1(8538):893-5 PMID: 2882294
  23. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria.
    Science. 1987 Sep 4;237(4819):1210-2 PMID: 3306918
  24. T cells in multiple sclerosis and inflammatory central nervous system diseases.
    Immunol Rev. 1987 Dec;100:307-32 PMID: 3326824
  25. Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions.
    J Neurol Sci. 1988 Apr;84(2-3):257-64 PMID: 3132537
  26. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro.
    Ann Neurol. 1988 Apr;23(4):339-46 PMID: 3132891
  27. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?
    Acta Neurol Scand. 1988 Oct;78(4):318-23 PMID: 3146861
  28. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement.
    Nature. 1989 Jun 22;339(6226):620-2 PMID: 2733792
  29. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.
    Lab Invest. 1989 Nov;61(5):489-503 PMID: 2811298
  30. Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody.
    Proc Natl Acad Sci U S A. 1989 Nov;86(22):9025-9 PMID: 2813437
  31. Apoptosis. The role of the endonuclease.
    Am J Pathol. 1990 Mar;136(3):593-608 PMID: 2156431
  32. Two proliferative stages of the oligodendrocyte lineage (A2B5+O4- and O4+GalC-) under different mitogenic control.
    Neuron. 1990 Nov;5(5):615-25 PMID: 2223090
  33. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis.
    J Neuroimmunol. 1991 Apr;32(1):67-74 PMID: 2002092
  34. Neuronal NADPH diaphorase is a nitric oxide synthase.
    Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2811-4 PMID: 1707173
  35. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation.
    J Neurol Sci. 1990 Dec;100(1-2):37-42 PMID: 2128520
  36. The pathogenesis of demyelinating disease: insights from cell biology.
    Trends Neurosci. 1991 May;14(5):175-82 PMID: 1713717
  37. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues.
    Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7797-801 PMID: 1715581
  38. Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders.
    J Neurol Sci. 1991 Aug;104(2):215-21 PMID: 1940975
  39. In vitro analysis of the origin and maintenance of O-2Aadult progenitor cells.
    J Cell Biol. 1992 Jan;116(1):167-76 PMID: 1730741
  40. Social controls on cell survival and cell death.
    Nature. 1992 Apr 2;356(6368):397-400 PMID: 1557121
  41. Identification of an interleukin 2-like substance as a factor cytotoxic to oligodendrocytes and associated with central nervous system regeneration.
    Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5442-6 PMID: 1608953
  42. Cell death and control of cell survival in the oligodendrocyte lineage.
    Cell. 1992 Jul 10;70(1):31-46 PMID: 1623522
  43. Interferon-gamma potentiates antibody-mediated demyelination in vivo.
    Ann Neurol. 1992 Aug;32(2):198-206 PMID: 1510359
  44. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
    J Cell Biol. 1992 Nov;119(3):493-501 PMID: 1400587
  45. In the presence of dexamethasone, gamma interferon induces rat oligodendrocytes to express major histocompatibility complex class II molecules.
    Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9054-8 PMID: 1409602
  46. Cytotoxicity of microglia.
    Glia. 1993 Jan;7(1):111-8 PMID: 8423058
  47. Toward an understanding of the molecular mechanisms of physiological cell death.
    Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):786-9 PMID: 8430086
  48. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death.
    Science. 1993 Jan 29;259(5095):689-92 PMID: 8430320
  49. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention.
    J Neurosci. 1993 Apr;13(4):1441-53 PMID: 8096541
  50. Interferon beta in multiple sclerosis.
    Neurology. 1993 Apr;43(4):641-3 PMID: 8469315
  51. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.
    Neurology. 1993 Apr;43(4):662-7 PMID: 8469319
Article Info
Journal
Molecular medicine (Cambridge, Mass.)
Abbr.
Mol Med
ISSN
1076-1551
Published
1995-11-00
Pages
732-43
Language
English
Region
England
NLM ID
9501023
PMCID
PMC2230017
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com